NO980289L - Bowman-Birk inhibitor sammensetninger for behandling av inflammatorisk sykdom - Google Patents

Bowman-Birk inhibitor sammensetninger for behandling av inflammatorisk sykdom

Info

Publication number
NO980289L
NO980289L NO980289A NO980289A NO980289L NO 980289 L NO980289 L NO 980289L NO 980289 A NO980289 A NO 980289A NO 980289 A NO980289 A NO 980289A NO 980289 L NO980289 L NO 980289L
Authority
NO
Norway
Prior art keywords
treatment
bowman
inflammatory disease
birk inhibitor
inhibitor compositions
Prior art date
Application number
NO980289A
Other languages
English (en)
Norwegian (no)
Other versions
NO980289D0 (no
Inventor
Ann R Kennedy
Paul C Billings
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of NO980289L publication Critical patent/NO980289L/no
Publication of NO980289D0 publication Critical patent/NO980289D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/56Protease inhibitors from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO980289A 1995-07-25 1998-01-22 Bowman-Birk inhibitor sammensetninger for behandling av inflammatorisk sykdom NO980289D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/507,044 US5614198A (en) 1995-07-25 1995-07-25 Bowman-Birk Inhibitor compositions for treatment of inflammatory disease
PCT/US1996/012173 WO1997004792A1 (en) 1995-07-25 1996-07-25 Bowman-birk inhibitor compositions for treatment of imflammatory disease

Publications (2)

Publication Number Publication Date
NO980289L true NO980289L (no) 1998-01-22
NO980289D0 NO980289D0 (no) 1998-01-22

Family

ID=24017040

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980289A NO980289D0 (no) 1995-07-25 1998-01-22 Bowman-Birk inhibitor sammensetninger for behandling av inflammatorisk sykdom

Country Status (13)

Country Link
US (1) US5614198A (de)
EP (1) EP0841933B1 (de)
JP (1) JP4026851B2 (de)
KR (1) KR19990035906A (de)
AT (1) ATE218877T1 (de)
AU (1) AU703476B2 (de)
CA (1) CA2223968A1 (de)
DE (1) DE69621805T2 (de)
DK (1) DK0841933T3 (de)
ES (1) ES2176475T3 (de)
NO (1) NO980289D0 (de)
PT (1) PT841933E (de)
WO (1) WO1997004792A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040166183A1 (en) * 1998-05-20 2004-08-26 Ruseler-Van Embden Johanna G. H. Methods and means for preventing or treating inflammation or pruritis
EP0958833A1 (de) * 1998-05-20 1999-11-24 Erasmus Universiteit Rotterdam Verfahren und Mittel zur Vorbeugung oder Behandlung der Entzündung
DE19906108A1 (de) * 1999-02-13 2000-08-17 Univ Eberhard Karls Schutz von Zellen im Zusammenhang mit einer Behandlung mit chemischen Agenzien
US6391848B1 (en) * 1999-04-30 2002-05-21 The Regents Of The University Of California Soybean protein nutraceuticals
US6767564B2 (en) * 2000-09-02 2004-07-27 The Trustees Of The University Of Pennsylvania Use of bowman birk inhibitor for the treatment of multiple sclerosis and other autoimmune diseases
US20080025966A1 (en) * 2004-01-30 2008-01-31 Currie Mark G Methods And Compositions For The Treatment Of Gastrointestinal disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4793996A (en) * 1984-11-14 1988-12-27 Ann R. Kennedy Method of making soybean extract inhibitor
JPS6351335A (ja) * 1986-08-20 1988-03-04 Fuji Oil Co Ltd 肥満細胞脱顆粒抑制剤
US5217717A (en) * 1990-09-06 1993-06-08 Central Soya Company, Inc. Method of making soybean Bowman-Birk inhibitor concentrate and use of same as a human cancer preventative and therapy
US5376373A (en) * 1990-09-06 1994-12-27 Trustees Of The University Of Pennsylvania Method of inhibiting radiation induced weight and hair loss
DK0512090T4 (da) * 1990-10-16 2007-01-15 Sonoran Desert Chemicals Llc Behandling af inflammation
IT1252865B (it) * 1991-12-31 1995-06-28 Lifegroup Spa N-acilderivati di aminoalcooli attivi come autocoidi locali ed utilizzabili nella terapia dei processi autoimmuni
SE9301911D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptide derivatives

Also Published As

Publication number Publication date
US5614198A (en) 1997-03-25
ES2176475T3 (es) 2002-12-01
EP0841933B1 (de) 2002-06-12
EP0841933A4 (de) 1998-08-05
CA2223968A1 (en) 1997-02-13
PT841933E (pt) 2002-10-31
ATE218877T1 (de) 2002-06-15
KR19990035906A (ko) 1999-05-25
JPH11510166A (ja) 1999-09-07
AU703476B2 (en) 1999-03-25
DE69621805D1 (de) 2002-07-18
DK0841933T3 (da) 2002-07-15
WO1997004792A1 (en) 1997-02-13
NO980289D0 (no) 1998-01-22
JP4026851B2 (ja) 2007-12-26
EP0841933A1 (de) 1998-05-20
AU6650196A (en) 1997-02-26
DE69621805T2 (de) 2003-03-20

Similar Documents

Publication Publication Date Title
NO995544L (no) Forbindelser og metoder for inhibering av ekspresjonen av VCAM-1
FI964287L (fi) Amidoamiinien käyttö silmälääkekoostumuksissa
UY24316A1 (es) Composiciones refrescantes
DE69618854D1 (de) Fotopolymerisierbare Zusammensetzung
BG103657A (en) New modifications of 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonylaminebenzene and methods for their prepration
ATE215366T1 (de) 3-benzoylphenylessigsäure-derivate enthaltende topische zusammensetzungen zur behandlung der ophthalmischen entzündungserkrankungen
PT941056E (pt) Composicoes de esfingomielinase e sua utilizacao
FI970044A7 (fi) Fraktioituja polydispersisiä koostumuksia
EP0865788A4 (de) Für cyclooxygenase 2 spezifischer inhibitor sowie entzündungshemmender stoff
ES2188759T3 (es) Derivados de la dolastatina, su preparacion y su uso.
DE69530860D1 (de) Behandlung der entzündung des sehnervs
EP0960191A4 (de) Zusammensetzungeen und verfahren zur verwendungen von defensin
DK0804078T3 (da) Sammensætning og anvendelse deraf
DE69400062D1 (de) Photopolymerisierbare Zusammensetzung
DE69609652D1 (de) Stabilisator-enthaltende gaserzeugende Zusammensetzungen
NO934218D0 (no) Inhibitorer av cathepsin G og elastase for forhindring avbindevevsnedbrytning
DE69720996D1 (de) Neue pharmazeutische zusammensetzungen von steroid-nitratester zur verwendung als enzündungshemmer
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
DE69621500D1 (de) Polymerisierbare Zusammensetzung
DE69604601D1 (de) Fotopolymerisierbare Zusammensetzung
NO20016068L (no) Anvendelse av oksypurin-nukleosider for fremstilling av et farmasöytisk preparat for redusering av inflammasjon i et dyr
DE69503738D1 (de) Fotopolymerisierbare Zusammensetzung
DK0771785T3 (da) Aminoesterforbindelser af parfumealkoholer og anvendelse deraf i rense- eller vaskesammensætninger
NO980289L (no) Bowman-Birk inhibitor sammensetninger for behandling av inflammatorisk sykdom
FI952459L (fi) Amidoamiinien käyttö oftalmisissa koostumuksissa

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application